Mustang Bio, Inc. Banner Image

Mustang Bio, Inc.

  • Ticker MBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Mustang Bio, Inc. Logo Image
  • 51-200 Employees
  • Based in Worcester, Massachusetts
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Mustang aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, to fund research and development, and to outlicenseMore or bring the technologies to market. Mustang has partnered with top medical institutions to advance the development of CAR T therapies across multiple cancers, as well as a lentiviral gene therapy for XSCID. Mustang is registered under the Securities Exchange Act of 1934, as amended, and files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). Mustang was founded by Fortress Biotech, Inc. (NASDAQ: FBIO).
4.8 / 5.0 (280)

Mustang Bio, Inc. reports have an aggregate usefulness score of 4.8 based on 280 reviews.

Mustang Bio, Inc.

Most Recent Annual Report

Mustang Bio, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Mustang Bio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!